According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...
The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...
A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
The Anti-Discrimination Act 2014 was passed into law to address stigma and discrimination-related offences, however, 11 years after, Persons Living with HIV are constantly faced with societal stigma, ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.